UMIN-CTR Clinical Trial

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000011573
Receipt No. R000013536
Scientific Title Discover of disease-susceptibility genes of ocular disease
Date of disclosure of the study information 2013/09/01
Last modified on 2020/03/04 (Ver. 5)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Discover of disease-susceptibility genes of ocular disease
Acronym SNPs of ocular diseases
Scientific Title Discover of disease-susceptibility genes of ocular disease
Scientific Title:Acronym SNPs of ocular diseases
Region
Japan

Condition
Condition Ocular disease patients and healthy volunteers
Classification by specialty
Ophthalmology
Classification by malignancy Others
Genomic information YES

Objectives
Narrative objectives1 Discover of disease-susceptibility genes of ocular diseases.
Basic objectives2 Others
Basic objectives -Others SNPs of ocular diseases
Trial characteristics_1 Exploratory
Trial characteristics_2
Developmental phase Not applicable

Assessment
Primary outcomes Revealing disease-susceptibility genes of ocular disease
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
18 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria (1)Ocular disease patients and healthy volunteers
(2)Patients who provided written informed consents to participate the study prior to enrollment
Key exclusion criteria Other conditions considered inappropriate by attending physician
Target sample size 4000

Research contact person
Name of lead principal investigator
1st name Kubota
Middle name
Last name Toshiaki
Organization Oita University Faculty of Medicine
Division name Department of Ophthalmology
Zip code 879-5593
Address 1-1 Idaigaoka, Hasama-machi, Yufu-City, Oita 879-5593, Japan
TEL 097-586-5904
Email oita_oph-admin@umin.ac.jp

Public contact
Name of contact person
1st name Nakano
Middle name
Last name Satoko
Organization Oita University Faculty of Medicine
Division name Department of Ophthalmology
Zip code 879-5593
Address 1-1 Idaigaoka, Hasama-machi, Yufu-City, Oita 879-5593, Japan
TEL 097-586-5904
Homepage URL
Email oita_oph-admin@umin.ac.jp

Sponsor
Institute Department of Ophthalmology, Oita University Faculty of Medicine
Institute
Department

Funding Source
Organization Self funding
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor Medical Foundation TENSHINDO
Oita Prefectural Hospital
Shinbeppu Hospital
BEPPU Medical Center
Name of secondary funder(s)

IRB Contact (For public release)
Organization Human Genome, Gene Analysis Research Ethics Committee, Oita University Faculty of Medicine
Address 1-1 Idaigaoka, Hasama-machi, Yufu-City, Oita 879-5593, Japan
Tel 097-586-5110
Email syomu@oita-u.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 大分大学医学部附属病院(大分県)
天心堂へつぎ病院(大分県)
大分県立病院(大分県)
新別府病院(大分県)
別府医療センター(大分県)

Other administrative information
Date of disclosure of the study information
2013 Year 09 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2013 Year 01 Month 01 Day
Date of IRB
2012 Year 11 Month 16 Day
Anticipated trial start date
2013 Year 01 Month 01 Day
Last follow-up date
2022 Year 12 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information SNPs of ocular disease

Management information
Registered date
2013 Year 08 Month 24 Day
Last modified on
2020 Year 03 Month 04 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000013536